Leading Pharma, LLC recalls Furosemide Tablets
- Recalling company
- Leading Pharma, LLC
- Product
- Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01
- Reason
- CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.
- Classification
- Class II – may cause temporary or medically reversible health consequences
- Recall date
- Mar 20, 2026
- Reported
- Apr 29, 2026
- Distribution
- US Nationwide.
- Status
- Ongoing
- Quantity
- 9384 bottles
- Lot / codes
- Lots# H03125, H03225, H03325, Exp Date: 2027/08
- Company location
- Fairfield, NJ
- Recall type
- Voluntary: Firm initiated
- Recall number
- D-0486-2026
- Agency
- U.S. Food and Drug Administration (FDA)
View official FDA notice ↗ Search recall number D-0486-2026 in the FDA Enforcement Report. Also see FDA recall press releases.
If you use this product, check the lot, NDC or model number against the official notice and follow its instructions. Do not stop a prescribed medicine or remove a medical device without talking to your doctor or pharmacist. Report problems to FDA MedWatch. FoodRecallNow summarizes public FDA data and is not medical advice.